Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2012

01-08-2012 | Correspondence

Is Nodular Gastritis a Precancerous Condition?

Author: Eda Demir Onal

Published in: Digestive Diseases and Sciences | Issue 8/2012

Login to get access

Excerpt

I read with great interest the article by Hong et al. [1]. They analyzed clinico-epidemiological characteristics of 52 patients with nodular gastritis (NG) and 2,527 controls. Gastric neoplasm was detected in a single patient in the NG group (1.9 %) and in five patients in the control group (0.2 %). In this study NG was associated with increased gastric neoplasia, including gastric adenoma and adenocarcinoma based on multivariate analysis (odds ratio = 10.52, 95 % CI [1.20–92.0]). The authors stated that the clinical implication of this finding was unclear because the range of the 95 % CI was notably wide and a positive association between NG and gastric neoplasm could not be found in the subgroup analysis comparing the Helicobacter pylori (−) controls or H. pylori (+) controls [1]. …
Literature
1.
go back to reference Hong SN, Jo S, Jang JH, et al. Clinical characteristics and the expression profiles of inflammatory cytokines/cytokine regulatory factors in asymptomatic patients with nodular gastritis. Dig Dis Sci. 2012;57:1486–1495. Hong SN, Jo S, Jang JH, et al. Clinical characteristics and the expression profiles of inflammatory cytokines/cytokine regulatory factors in asymptomatic patients with nodular gastritis. Dig Dis Sci. 2012;57:1486–1495.
2.
go back to reference Miyamoto M, Haruma K, Yoshihara M, et al. Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. Dig Liver Dis. 2002;34:819–820.PubMedCrossRef Miyamoto M, Haruma K, Yoshihara M, et al. Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. Dig Liver Dis. 2002;34:819–820.PubMedCrossRef
3.
go back to reference Miyamoto M, Haruma K, Yoshihara M, et al. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis Sci. 2003;48:968–975.PubMedCrossRef Miyamoto M, Haruma K, Yoshihara M, et al. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis Sci. 2003;48:968–975.PubMedCrossRef
4.
go back to reference Onal IK, Sokmensuer C, Onal ED, et al. Clinical and pathological features of nodular gastritis in adults. Turk J Med Sci. 2009;39:719–723. Onal IK, Sokmensuer C, Onal ED, et al. Clinical and pathological features of nodular gastritis in adults. Turk J Med Sci. 2009;39:719–723.
5.
go back to reference Sokmensuer C, Onal IK, Yeniova O, et al. What are the clinical implications of nodular gastritis? Clues from histopathology. Dig Dis Sci. 2009;54:2150–2154.PubMedCrossRef Sokmensuer C, Onal IK, Yeniova O, et al. What are the clinical implications of nodular gastritis? Clues from histopathology. Dig Dis Sci. 2009;54:2150–2154.PubMedCrossRef
Metadata
Title
Is Nodular Gastritis a Precancerous Condition?
Author
Eda Demir Onal
Publication date
01-08-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2265-6

Other articles of this Issue 8/2012

Digestive Diseases and Sciences 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.